<DOC>
	<DOCNO>NCT01060124</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Transdermal Therapeutic System ( TTS ) -fentanyl D-Trans ( transdermal patch contain drug put skin drug enter body skin ) treatment cancer participant Korea inadequately control pain non-narcotic analgesic ( drug use control pain ) participant 's satisfaction .</brief_summary>
	<brief_title>An Efficacy Safety Study Transdermal Therapeutic System ( TTS ) -Fentanyl Cancer Participants With Inadequately Controlled Pain Non-Narcotic Analgesics</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , single-arm , multicenter ( conduct one hospital medical school team work medical research study ) , prospective ( study follow participant forward time ) study conduct assess efficacy safety TTS-fentanyl D-trans cancer participant Korea inadequately control pain non-narcotic analgesic participant 's satisfaction . The participant receive initial dose TTS-fentanyl D-trans patch release 12 microgram per hour ( 12 mcg/hr ) fentanyl increase 12 mcg/hr 25 mcg/hr , every 3 day depend participant 's pain control . Efficacy primarily evaluate participant 's satisfaction pain treatment . Participant 's safety monitor throughout study .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Participants complain cancer pain Participants take nonopioid analgesic past one month cancer pain relief purpose , still average 4 high pain level Visual Analogue Scale ( VAS ) last 24 hour Participants estimate life expectancy least 2 month Participants able communicate investigator Participants avoid get pregnant appropriately possibility pregnancy study period Participants participate another clinical trial Participants history oversensitive reaction narcotic analgesic exist history drug abuse Participants active skin disease , avoid application transdermal system Participants history CO2 ( carbon dioxide ) retention ( i.e . chronic obstructive pulmonary disease ) Participants undergoing chemotherapy/radiotherapy right go get chemotherapy/radiotherapy within study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Pain ; Cancer</keyword>
	<keyword>TTS-Fentanyl D-trans</keyword>
	<keyword>Durogesic D-trans</keyword>
</DOC>